Mettler-Toledo International, Inc. $MTD Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC lifted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 2.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 597,448 shares of the medical instruments supplier’s stock after purchasing an additional 14,106 shares during the period. Geode Capital Management LLC’s holdings in Mettler-Toledo International were worth $830,879,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Geneos Wealth Management Inc. boosted its holdings in Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after purchasing an additional 30 shares during the period. Baird Financial Group Inc. boosted its holdings in Mettler-Toledo International by 3.1% in the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after purchasing an additional 40 shares during the period. Jump Financial LLC boosted its holdings in Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after purchasing an additional 125 shares during the period. Cerity Partners LLC boosted its holdings in Mettler-Toledo International by 10.8% in the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after purchasing an additional 392 shares during the period. Finally, AXA S.A. boosted its holdings in Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after purchasing an additional 131 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on MTD shares. JPMorgan Chase & Co. reduced their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Citigroup reduced their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Finally, Wall Street Zen cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Moderate Buy” and an average price target of $1,408.55.

Mettler-Toledo International Stock Up 1.6%

Shares of MTD opened at $1,181.99 on Friday. The stock has a 50 day moving average price of $1,221.65 and a 200 day moving average price of $1,332.06. The company has a market capitalization of $23.89 billion, a price-to-earnings ratio of 27.72, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the company posted $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.